Physician profile
Christopher Chen
NPI 1891738472
$33,861.41
in general payments reported to CMS, 2019-2025
15 companies · $33K in 2025
The $33K reported for 2025 was more than what 99% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $486 · 2020: $16.96 · 2021: $91.88 · 2022: $36.72 · 2023: $191 · 2024: $126 · 2025: $33K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Acquisitions: $33K · Food and Beverage: $378.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Acquisitions | $32,852.47 |
| Food and Beverage | $377.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $32,852.47 | 2025 | |
| Daiichi Sankyo INC. | $158.18 | 2019 | |
| Collegium Pharmaceutical, INC. | $148.29 | 2021-2024 | Belbuca |
| Abbvie INC. | $147.82 | 2023 | Ubrelvy, Qulipta |
| Gilead Sciences, INC. | $106.34 | 2019 | |
| Abbott Laboratories | $104.93 | 2019-2025 | Proclaim, Eterna |
| Depuy Synthes Sales INC. | $79.53 | 2019 | |
| Kaleo, INC. | $68.56 | 2019 | |
| Inari Medical, INC. | $62.70 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Galderma Laboratories, L.P. | $35.59 | 2025 | |
| Atricure, INC. | $27.60 | 2024 | |
| Mdd US Operations, LLC | $22.68 | 2019 | |
| Scilex Pharmaceuticals INC. | $17.10 | 2022 | |
| Orexo US, INC. | $16.96 | 2020 | |
| Shionogi INC | $12.66 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.